• Raipur Chhattisgarh
  • info@cbmeds.in
  • 24/7 Customer Support
Facebook Twitter Github Bitbucket

TOMORROW'S MEDICINES TODAY

Lung Cancer

Lung Cancer Medicine Access for International Patients: A Complete Guide

Leave a Comment / Blog, Lung Cancer, Patient Guide /

Introduction Receiving a lung cancer diagnosis can be overwhelming. For many patients, the next challenge is not choosing a treatment—it’s finding access to the medicine their oncologist has prescribed. In many parts of the world, targeted lung cancer medicines may not yet be available, may be temporarily out of stock, or may be priced beyond […]

Lung Cancer Medicine Access for International Patients: A Complete Guide Read More »

Osimertinib NSCLC First-Line Treatment: A Complete Patient Guide

Leave a Comment / Blog, EGFR, Lung Cancer, Osimertinib /

Introduction The treatment landscape for non-small cell lung cancer (NSCLC) has changed dramatically over the past decade. For patients whose tumors carry specific EGFR (Epidermal Growth Factor Receptor) mutations, targeted therapies have significantly improved survival and quality of life compared with traditional chemotherapy. Among these targeted treatments, Osimertinib has become the preferred first-line treatment for

Osimertinib NSCLC First-Line Treatment: A Complete Patient Guide Read More »

Osimertinib for EGFR Mutation (T790M): Complete Patient Guide

Leave a Comment / Blog, EGFR, Lung Cancer, Osimertinib /

Introduction For many patients with EGFR-mutated non-small cell lung cancer (NSCLC), targeted therapy has transformed treatment outcomes. Earlier EGFR inhibitors helped many patients control their cancer for months or even years. However, over time, some cancers develop resistance, making these medicines less effective. One of the most common resistance mechanisms is the EGFR T790M mutation.

Osimertinib for EGFR Mutation (T790M): Complete Patient Guide Read More »

The Hidden Cost of Cancer: More Than Just Medical Bills

Leave a Comment / Blog, Lung Cancer, Osimertinib, Patient Guide /

Introduction When someone is diagnosed with cancer, the first concern is naturally their health. Questions about treatment, recovery, and survival quickly take center stage. But for millions of patients and families worldwide, another battle begins almost immediately—the hidden financial and emotional cost of living with cancer. Cancer is not only a medical condition. It is

The Hidden Cost of Cancer: More Than Just Medical Bills Read More »

osimertinib resistance

Osimertinib Resistance — Causes and What Happens Next

Leave a Comment / Blog, EGFR, Lung Cancer /

For patients doing well on Osimertinib, the possibility that it might eventually stop working can be a source of anxiety. This is a valid concern — like most targeted cancer therapies, Osimertinib resistance can develop over time. This guide explains why resistance happens, how it is detected, and importantly, what treatment options exist afterward. Understanding

Osimertinib Resistance — Causes and What Happens Next Read More »

named patient medicine

Named Patient Medicine Explained — How Patients Legally Access Unavailable Medicines

Leave a Comment / Blog, Lung Cancer /

If you have been researching how to access a medicine like Osimertinib that isn’t available or affordable in your country, you have likely come across the term “Named Patient Medicine.” This guide explains exactly what it means, why it exists, and how it works in practice. What is Named Patient Medicine? Named Patient Medicine (NPM)

Named Patient Medicine Explained — How Patients Legally Access Unavailable Medicines Read More »

osimertinib brain metastasis

Osimertinib and Brain Metastasis — What the Research Shows

Leave a Comment / Blog, EGFR, Lung Cancer /

For patients with EGFR-mutated NSCLC, one of the most worrying possibilities is that the cancer could spread to the brain. Brain metastases occur in a significant proportion of advanced lung cancer patients, and historically, treating cancer that has spread to the brain has been particularly difficult. This is where Osimertinib has made a genuine difference.

Osimertinib and Brain Metastasis — What the Research Shows Read More »

osimertinib dosage

Osimertinib 40mg vs 80mg: Which Dose Is Right for You? (2026 Guide)

Leave a Comment / Blog, Osimertinib, Patient Guide /

One of the most common questions patients and caregivers ask after a new prescription is simple: why this dose, and not the other one? Osimertinib is available in two strengths — 40 mg and 80 mg — and the choice between them depends on several factors specific to each patient. This guide explains how Osimertinib

Osimertinib 40mg vs 80mg: Which Dose Is Right for You? (2026 Guide) Read More »

How to Access Osimertinib in India Legally — A Step-by-Step Guide

Leave a Comment / Lung Cancer, Osimertinib /

One of the most common questions we receive at CBMeds is: “Is it legal to get Osimertinib from India?” The answer is yes. This guide explains exactly how it works, what documents you need, and what the process looks like from first inquiry to doorstep delivery. Whether you are a patient, a family member, or

How to Access Osimertinib in India Legally — A Step-by-Step Guide Read More »

We are committed to the Ethical Principles of the World Medical Association.

We are registered and audited by the Dutch Ministry of Health in The Hague as an Independent Intermediary for Medicines, registration number 6730 BEM and as a Pharmaceutical Distributor with the registration number 16258 G.

We support the United Nation’s 2030 Sustainable Development Goals related to Health and Equality.

ABOUT US

As a social impact enterprise, our core values are all about supporting Health, Freedom, and Opportunity.

 

(c) 2020 All Rights Reserved. Powered By Gray Arc

MENU

  • Privacy Policy
  • Terms of Use
  • Help & Support
  • About Us

SOCIAL

Instagram Facebook-f Linkedin-in Quora